1 1715 148 DYSLIPIDEMIC DIET-INDUCED MONOCYTE "PRIMING" AND DYSFUNCTION IN NON-HUMAN PRIMATES IS TRIGGERED BY ELEVATED PLASMA CHOLESTEROL AND ACCOMPANIED BY ALTERED HISTONE ACETYLATION. MONOCYTES AND THE RECRUITMENT OF MONOCYTE-DERIVED MACROPHAGES INTO SITES OF INFLAMMATION PLAY A KEY ROLE IN ATHEROGENESIS AND OTHER CHRONIC INFLAMMATORY DISEASES LINKED TO CARDIOMETABOLIC SYNDROME AND OBESITY. PREVIOUS STUDIES FROM OUR GROUP HAVE SHOWN THAT METABOLIC STRESS PROMOTES MONOCYTE PRIMING, I.E., ENHANCED ADHESION AND ACCELERATED CHEMOTAXIS OF MONOCYTES IN RESPONSE TO CHEMOKINES, BOTH IN VITRO AND IN DYSLIPIDEMIC LDLR(-/-) MICE. WE ALSO SHOWED THAT METABOLIC STRESS-INDUCED MONOCYTE DYSFUNCTION IS, AT LEAST TO A LARGE EXTENT CAUSED BY THE S-GLUTATHIONYLATION, INACTIVATION, AND SUBSEQUENT DEGRADATION OF MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE 1. HERE, WE ANALYZED THE EFFECTS OF A WESTERN-STYLE, DYSLIPIDEMIC DIET (DD), WHICH WAS COMPOSED OF HIGH LEVELS OF SATURATED FAT, CHOLESTEROL, AND SIMPLE SUGARS, ON MONOCYTE (DYS)FUNCTION IN NON-HUMAN PRIMATES (NHPS). WE FOUND THAT SIMILAR TO MICE, A DD ENHANCES MONOCYTE CHEMOTAXIS IN NHP WITHIN 4 WEEKS, OCCURRING CONCORDANTLY WITH THE ONSET OF HYPERCHOLESTEROLEMIA BUT PRIOR TO CHANGES IN TRIGLYCERIDES, BLOOD GLUCOSE, MONOCYTOSIS, OR CHANGES IN MONOCYTE SUBSET COMPOSITION. IN ADDITION, WE IDENTIFIED TRANSITORY DECREASES IN THE ACETYLATION OF HISTONE H3 AT THE LYSINE RESIDUES 18 AND 23 IN METABOLICALLY PRIMED MONOCYTES, AND WE FOUND THAT MONOCYTE PRIMING WAS CORRELATED WITH THE ACETYLATION OF HISTONE H3 AT LYSINE 27 AFTER AN 8-WEEK DD REGIMEN. OUR DATA SHOW THAT METABOLIC STRESS PROMOTES MONOCYTE PRIMING AND HYPER-CHEMOTACTIC RESPONSES IN NHP. THE HISTONE MODIFICATIONS ACCOMPANYING MONOCYTE PRIMING IN PRIMATES SUGGEST A REPROGRAMMING OF THE EPIGENETIC LANDSCAPE, WHICH MAY LEAD TO DYSREGULATED RESPONSES AND FUNCTIONALITIES IN MACROPHAGES DERIVED FROM PRIMED MONOCYTES THAT ARE RECRUITED TO SITES OF INFLAMMATION. 2017 2 5453 26 REPROGRAMMING OF COPD LUNG FIBROBLASTS THROUGH FORMATION OF INDUCED PLURIPOTENT STEM CELLS. REPROGRAMMING SOMATIC CELLS TO INDUCED PLURIPOTENT STEM CELLS (IPSCS) ELIMINATES MANY EPIGENETIC MODIFICATIONS THAT CHARACTERIZE DIFFERENTIATED CELLS. IN THIS STUDY, WE TESTED WHETHER FUNCTIONAL DIFFERENCES BETWEEN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND NON-COPD FIBROBLASTS COULD BE REDUCED UTILIZING THIS APPROACH. PRIMARY FIBROBLASTS FROM NON-COPD AND COPD PATIENTS WERE REPROGRAMMED TO IPSCS. REPROGRAMMED IPSCS WERE POSITIVE FOR OCT3/4, NANOG, AND SOX2, FORMED EMBRYOID BODIES IN VITRO, AND INDUCED TERATOMAS IN NONOBESE DIABETIC/SEVERE COMBINED IMMUNODEFICIENT MICE. REPROGRAMMED IPSCS WERE THEN DIFFERENTIATED INTO FIBROBLASTS (NON-COPD-I AND COPD-I) AND WERE ASSESSED EITHER FUNCTIONALLY BY CHEMOTAXIS AND GEL CONTRACTION OR FOR GENE EXPRESSION BY MICROARRAYS AND COMPARED WITH THEIR CORRESPONDING PRIMARY FIBROBLASTS. PRIMARY COPD FIBROBLASTS CONTRACTED THREE-DIMENSIONAL COLLAGEN GELS AND MIGRATED TOWARD FIBRONECTIN LESS ROBUSTLY THAN NON-COPD FIBROBLASTS. IN CONTRAST, REDIFFERENTIATED FIBROBLASTS FROM IPSCS DERIVED FROM THE NON-COPD AND COPD FIBROBLASTS WERE SIMILAR IN RESPONSE IN BOTH FUNCTIONAL ASSAYS. MICROARRAY ANALYSIS IDENTIFIED 1,881 GENES THAT WERE DIFFERENTIALLY EXPRESSED BETWEEN PRIMARY COPD AND NON-COPD FIBROBLASTS, WITH 605 GENES DIFFERING BY MORE THAN TWOFOLD. AFTER REDIFFERENTIATION, 112 GENES WERE DIFFERENTIALLY EXPRESSED BETWEEN COPD-I AND NON-COPD-I WITH ONLY THREE GENES BY MORE THAN TWOFOLD. SIMILAR FINDINGS WERE OBSERVED WITH MICRORNA (MIRNA) EXPRESSION: 56 MIRNAS WERE DIFFERENTIALLY EXPRESSED BETWEEN NON-COPD AND COPD PRIMARY CELLS; AFTER REDIFFERENTIATION, ONLY 3 MIRNAS WERE DIFFERENTIALLY EXPRESSED BETWEEN NON-COPD-I AND COPD-I FIBROBLASTS. INTERESTINGLY, OF THE 605 GENES THAT WERE DIFFERENTIALLY EXPRESSED BETWEEN COPD AND NON-COPD FIBROBLASTS, 293 GENES WERE CHANGED TOWARD CONTROL AFTER REDIFFERENTIATION. IN CONCLUSION, FUNCTIONAL AND EPIGENETIC ALTERATIONS OF COPD FIBROBLASTS CAN BE REPROGRAMMED THROUGH FORMATION OF IPSCS. 2014 3 4081 34 MATERNAL MICRONUTRIENT SUPPLEMENTATION SUPPRESSES T CELL CHEMOKINE RECEPTOR EXPRESSION AND FUNCTION IN F1 MICE. PRENATAL ENVIRONMENTAL EXPOSURES PLAY A CRITICAL ROLE IN DETERMINING LATE-LIFE CHRONIC DISEASE SUSCEPTIBILITY. HOWEVER, THE MECHANISMS LINKING THE IN UTERO ENVIRONMENT AND DISEASE DEVELOPMENT IN THE OFFSPRING ARE POORLY UNDERSTOOD. RECENT INVESTIGATIONS HAVE CONFIRMED A CENTRAL PATHOGENIC ROLE OF T CELL CHEMOKINE RECEPTORS, PARTICULARLY C-C CHEMOKINE RECEPTOR (CCR) 2 AND CCR5, IN CHRONIC INFLAMMATORY CONDITIONS. THIS STUDY WAS DESIGNED TO DETERMINE THE EFFECT OF A SYNTHETIC PRENATAL MICRONUTRIENT SUPPLEMENTATION (MS) DIET RICH IN METHIONINE PATHWAY METABOLITES ON THE T CELL CHEMOKINE SYSTEM IN F1 C57BL/6 MICE. FEMALE MICE WERE FED EITHER AN MS OR CONTROL DIET 3 WK PRIOR TO MATING, DURING PREGNANCY, AND LACTATION. AT 4 WK OF AGE, F1 MICE WERE KILLED FOR EXPERIMENTS OR WERE FED THE STANDARD NIH-31 DIET AND ALLOWED TO AGE. FOOD CONSUMPTION, MATERNAL WEIGHT GAIN, AND LITTER SIZE WERE SIMILAR IN DAMS FED THE CONTROL AND MS DIETS. HOWEVER, THE F1 OFFSPRING OF DAMS FED THE MS DIET WERE SMALLER IN SIZE (P < 0.001). T CELLS FROM THE MS F1 OFFSPRING HAD GLOBAL HYPERMETHYLATION COMPARED WITH CONTROL F1 OFFSPRING (P < 0.005), CORRESPONDING TO LOWER T CELL CHEMOKINE RECEPTOR EXPRESSION [CCR2 (P < 0.001), CCR5 (P < 0.001), AND C-X-C CHEMOKINE RECEPTOR 3 (P < 0.01)] AND CYTOKINE EXPRESSION [TNFALPHA (P < 0.05), IL-2 (P < 0.001), AND IL-4 (P < 0.01)]. REDUCED T CELL CHEMOKINE RECEPTOR GENE EXPRESSION IN MS F1 MICE WAS ASSOCIATED WITH DECREASED CHEMOTAXIS IN VITRO TO C-C CHEMOKINE LIGAND (CCL) 2 AND C-X-C CHEMOKINE LIGAND 10 (P < 0.01) AND IN VIVO TO CCL2 (P < 0.01). TAKEN TOGETHER, THE RESULTS SUGGEST THAT EPIGENETIC ALTERATION THROUGH PRENATAL DIET MANIPULATION REDUCES THE RESPONSE TO PROINFLAMMATORY SIGNALS IN MICE. 2012 4 5539 25 ROLE OF CYSTIC FIBROSIS BRONCHIAL EPITHELIUM IN NEUTROPHIL CHEMOTAXIS. A HALLMARK OF CYSTIC FIBROSIS (CF) CHRONIC RESPIRATORY DISEASE IS AN EXTENSIVE NEUTROPHIL INFILTRATE IN THE MUCOSA FILLING THE BRONCHIAL LUMEN, STARTING EARLY IN LIFE FOR CF INFANTS. THE GENETIC DEFECT OF THE CF TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) ION CHANNEL PROMOTES DEHYDRATION OF THE AIRWAY SURFACE LIQUID, ALTERS MUCUS PROPERTIES, AND DECREASES MUCOCILIARY CLEARANCE, FAVORING THE ONSET OF RECURRENT AND, ULTIMATELY, CHRONIC BACTERIAL INFECTION. NEUTROPHIL INFILTRATES ARE UNABLE TO CLEAR BACTERIAL INFECTION AND, AS AN ADVERSE EFFECT, CONTRIBUTE TO MUCOSAL TISSUE DAMAGE BY RELEASING PROTEASES AND REACTIVE OXYGEN SPECIES. MOREOVER, THE RAPID CELLULAR TURNOVER OF LUMENAL NEUTROPHILS RELEASES NUCLEIC ACIDS THAT FURTHER ALTER THE MUCUS VISCOSITY. A PROMINENT ROLE IN THE RECRUITMENT OF NEUTROPHIL IN BRONCHIAL MUCOSA IS PLAYED BY CF BRONCHIAL EPITHELIAL CELLS CARRYING THE DEFECTIVE CFTR PROTEIN AND ARE EXPOSED TO WHOLE BACTERIA AND BACTERIAL PRODUCTS, MAKING PHARMACOLOGICAL APPROACHES TO REGULATE THE EXAGGERATED NEUTROPHIL CHEMOTAXIS IN CF A RELEVANT THERAPEUTIC TARGET. HERE WE REVISE: (A) THE MAJOR RECEPTORS, KINASES, AND TRANSCRIPTION FACTORS LEADING TO THE EXPRESSION, AND RELEASE OF NEUTROPHIL CHEMOKINES IN BRONCHIAL EPITHELIAL CELLS; (B) THE ROLE OF INTRACELLULAR CALCIUM HOMEOSTASIS AND, IN PARTICULAR, THE CALCIUM CROSSTALK BETWEEN ENDOPLASMIC RETICULUM AND MITOCHONDRIA; (C) THE EPIGENETIC REGULATION OF THE KEY CHEMOKINES; (D) THE ROLE OF MUTANT CFTR PROTEIN AS A CO-REGULATOR OF CHEMOKINES TOGETHER WITH THE HOST-PATHOGEN INTERACTIONS; AND (E) DIFFERENT PHARMACOLOGICAL STRATEGIES TO REGULATE THE EXPRESSION OF CHEMOKINES IN CF BRONCHIAL EPITHELIAL CELLS THROUGH NOVEL DRUG DISCOVERY AND DRUG REPURPOSING. 2020 5 3192 20 HDAC INHIBITION COUNTERACTS METASTATIC RE-ACTIVATION OF PROSTATE CANCER CELLS INDUCED BY CHRONIC MTOR SUPPRESSION. THIS STUDY WAS DESIGNED TO INVESTIGATE WHETHER EPIGENETIC MODULATION BY HISTONE DEACETYLASE (HDAC) INHIBITION MIGHT CIRCUMVENT RESISTANCE TOWARDS THE MECHANISTIC TARGET OF RAPAMYCIN (MTOR) INHIBITOR TEMSIROLIMUS IN A PROSTATE CANCER CELL MODEL. PARENTAL (PAR) AND TEMSIROLIMUS-RESISTANT (RES) PC3 PROSTATE CANCER CELLS WERE EXPOSED TO THE HDAC INHIBITOR VALPROIC ACID (VPA), AND TUMOR CELL ADHESION, CHEMOTAXIS, MIGRATION, AND INVASION WERE EVALUATED. TEMSIROLIMUS RESISTANCE WAS CHARACTERIZED BY REDUCED BINDING OF PC3(RES) CELLS TO ENDOTHELIUM, IMMOBILIZED COLLAGEN, AND FIBRONECTIN, BUT INCREASED ADHESION TO LAMININ, AS COMPARED TO THE PARENTAL CELLS. CHEMOTAXIS, MIGRATION, AND INVASION OF PC3(RES) CELLS WERE ENHANCED FOLLOWING TEMSIROLIMUS RE-TREATMENT. INTEGRIN ALPHA AND BETA RECEPTORS WERE SIGNIFICANTLY ALTERED IN PC3(RES) COMPARED TO PC3(PAR) CELLS. VPA SIGNIFICANTLY COUNTERACTED TEMSIROLIMUS RESISTANCE BY DOWN-REGULATING TUMOR CELL(-)MATRIX INTERACTION, CHEMOTAXIS, AND MIGRATION. EVALUATION OF INTEGRIN EXPRESSION IN THE PRESENCE OF VPA REVEALED A SIGNIFICANT DOWN-REGULATION OF INTEGRIN ALPHA5 IN PC3(RES) CELLS. BLOCKING STUDIES DEMONSTRATED A CLOSE ASSOCIATION BETWEEN ALPHA5 EXPRESSION ON PC3(RES) AND CHEMOTAXIS. IN THIS IN VITRO MODEL, TEMSIROLIMUS RESISTANCE DROVE PROSTATE CANCER CELLS TO BECOME HIGHLY MOTILE, WHILE HDAC INHIBITION REVERSED THE METASTATIC ACTIVITY. THE VPA-INDUCED INHIBITION OF METASTATIC ACTIVITY WAS ACCOMPANIED BY A LOWERED INTEGRIN ALPHA5 SURFACE LEVEL ON THE TUMOR CELLS. 2018 6 4564 32 MYELOID KDM6B DEFICIENCY RESULTS IN ADVANCED ATHEROSCLEROSIS. BACKGROUND AND AIMS: ATHEROSCLEROSIS IS A LIPID-DRIVEN CHRONIC INFLAMMATORY DISORDER OF THE ARTERIES, AND MONOCYTES AND MACROPHAGES PLAY A CENTRAL ROLE IN THIS PROCESS. WITHIN THE ATHEROSCLEROTIC LESION, MACROPHAGES CAN SCAVENGE MODIFIED LIPIDS AND BECOME THE SO-CALLED FOAM CELLS. WE PREVIOUSLY REPORTED THAT THE EPIGENETIC ENZYME KDM6B (ALSO KNOWN AS JMJD3) CONTROLS THE PRO-FIBROTIC TRANSCRIPTIONAL PROFILE OF PERITONEAL FOAM CELLS. GIVEN THE IMPORTANCE OF THESE CELLS IN ATHEROSCLEROSIS, WE NOW STUDIED THE EFFECT OF MYELOID KDM6B ON DISEASE PROGRESSION. METHODS: BONE MARROW OF MYELOID KDM6B DEFICIENT (KDM6B(DEL)) MICE OR WILD TYPE LITTERMATES (KDM6B(WT)) WAS TRANSPLANTED TO LETHALLY IRRADIATED LDLR(-/-) MICE FED A HIGH FAT DIET FOR 9 WEEKS TO INDUCE ATHEROSCLEROSIS. RESULTS: LESION SIZE WAS SIMILAR IN KDM6B(WT) AND KDM6B(DEL) TRANSPLANTED MICE. HOWEVER, LESIONS OF KDM6B(DEL) MICE CONTAINED MORE COLLAGEN AND WERE MORE NECROTIC. PATHWAY ANALYSIS ON PERITONEAL FOAM CELLS SHOWED THAT THE PATHWAY INVOLVED IN LEUKOCYTE CHEMOTAXIS WAS MOST SIGNIFICANTLY UPREGULATED. ALTHOUGH MACROPHAGE AND NEUTROPHIL CONTENT WAS SIMILAR AFTER 9 WEEKS OF HIGH FAT DIET FEEDING, THE RELATIVE INCREASE IN COLLAGEN CONTENT AND NECROSIS REVEALED THAT ATHEROSCLEROTIC LESIONS IN KDM6B(DEL) MICE PROGRESS FASTER. CONCLUSION: MYELOID KDM6B DEFICIENCY RESULTS IN MORE ADVANCED ATHEROSCLEROSIS. 2018 7 362 37 AMBIENT AIR POLLUTION IMPAIRS REGULATORY T-CELL FUNCTION IN ASTHMA. BACKGROUND: ASTHMA IS THE MOST FREQUENT CHRONIC DISEASE IN CHILDREN, AND CHILDREN ARE AT HIGH RISK FOR ADVERSE HEALTH CONSEQUENCES ASSOCIATED WITH AMBIENT AIR POLLUTION (AAP) EXPOSURE. REGULATORY T (TREG) CELLS ARE SUPPRESSORS OF IMMUNE RESPONSES INVOLVED IN ASTHMA PATHOGENESIS. TREG-CELL IMPAIRMENT IS ASSOCIATED WITH INCREASED DNA METHYLATION OF FORKHEAD BOX TRANSCRIPTION FACTOR 3 (FOXP3), A KEY TRANSCRIPTION FACTOR IN TREG-CELL ACTIVITY. BECAUSE AAP EXPOSURE CAN INDUCE EPIGENETIC CHANGES, WE HYPOTHESIZED THAT TREG-CELL FUNCTION WOULD BE IMPAIRED BY AAP, ALLOWING AMPLIFICATION OF AN INFLAMMATORY RESPONSE. OBJECTIVES: TO ASSESS WHETHER EXPOSURE TO AAP LED TO HYPERMETHYLATION OF THE FOXP3 GENE, CAUSING IMPAIRED TREG-CELL SUPPRESSION AND WORSENED ASTHMA SYMPTOM SCORES. METHODS: CHILDREN WITH AND WITHOUT ASTHMA FROM FRESNO, CALIF (HIGH POLLUTION, FRESNO ASTHMA GROUP [FA], N = 71, AND FRESNO NON ASTHMATIC GROUP, N = 30, RESPECTIVELY), AND FROM STANFORD, CALIF (LOW POLLUTION, STANFORD ASTHMA GROUP, N = 40, AND STANFORD NON ASTHMATIC GROUP, N = 40), WERE ENROLLED IN A CROSS-SECTIONAL STUDY. PERIPHERAL BLOOD TREG CELLS WERE USED IN FUNCTIONAL AND EPIGENETIC STUDIES. ASTHMA OUTCOMES WERE ASSESSED BY GLOBAL INITIATIVE IN ASTHMA SCORE. RESULTS: FRESNO ASTHMA GROUP TREG-CELL SUPPRESSION WAS IMPAIRED AND FA TREG-CELL CHEMOTAXIS WERE REDUCED COMPARED WITH OTHER GROUPS (P /= 12 WK) HYPERGLYCEMIA FEATURES INCREASED BACTERIAL LOAD, OVERPRODUCTION OF SEVERAL CYTOKINES, AND INCREASED IMMUNE PATHOLOGY COMPARED WITH NORMOGLYCEMIC CONTROLS. A SIMILAR PHENOTYPE EXISTS IN HUMAN PATIENTS WITH DIABETES WITH TB. THE MECHANISMS OF INCREASED T CELL ACTIVATION IN DIABETES ARE UNKNOWN. IN THE CURRENT STUDY, WE TESTED THE HYPOTHESIS THAT HYPERGLYCEMIA MODIFIES THE INTRINSIC RESPONSIVENESS OF NAIVE T CELLS TO TCR STIMULATION. PURIFIED T CELLS FROM CHRONICALLY HYPERGLYCEMIC (HG) MICE PRODUCED HIGHER LEVELS OF TH1, TH2, AND TH17 CYTOKINES AND PROLIFERATED MORE THAN T CELLS FROM NORMOGLYCEMIC CONTROLS AFTER ANTI-CD3E OR AG STIMULATION. IN THIS WAY, NAIVE T CELLS FROM HG MICE RESEMBLED AG-EXPERIENCED CELLS, ALTHOUGH CD44 EXPRESSION WAS NOT INCREASED. CHROMATIN DECONDENSATION, ANOTHER CHARACTERISTIC OF AG-EXPERIENCED T CELLS, WAS INCREASED IN NAIVE T CELLS FROM HG MICE. THAT PHENOTYPE DEPENDED ON EXPRESSION OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND COULD BE REVERSED BY INHIBITING P38 MAPK. CHROMATIN DECONDENSATION AND HYPERRESPONSIVENESS TO TCR STIMULATION PERSISTED FOLLOWING TRANSFER OF T CELLS FROM HG MICE INTO NORMOGLYCEMIC MICE. WE PROPOSE THAT CHRONIC HYPERGLYCEMIA CAUSES RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS-MEDIATED EPIGENETIC MODIFICATION OF NAIVE T CELLS LEADING TO P38 MAPK-DEPENDENT CHROMATIN DECONDENSATION. THIS PREACTIVATION STATE FACILITATES TRANSCRIPTION FACTOR ACCESS TO DNA, INCREASING CYTOKINE PRODUCTION AND PROLIFERATION FOLLOWING TCR STIMULATION. THIS MECHANISM MAY CONTRIBUTE TO PATHOLOGICAL INFLAMMATION ASSOCIATED WITH DIABETES AND MIGHT OFFER A NOVEL THERAPEUTIC TARGET. 2014 20 6111 29 THE EPIGENETIC ARCHITECTURE AT GENE PROMOTERS DETERMINES CELL TYPE-SPECIFIC LPS TOLERANCE. SYNOVIAL FIBROBLASTS (SF) DRIVE INFLAMMATION AND JOINT DESTRUCTION IN CHRONIC ARTHRITIS. HERE WE SHOW THAT SF POSSESS A DISTINCT TYPE OF LPS TOLERANCE COMPARED TO MACROPHAGES AND OTHER TYPES OF FIBROBLASTS. IN SF AND DERMAL FIBROBLASTS, GENES THAT WERE NON-TOLERIZABLE AFTER REPEATED LPS STIMULATION INCLUDED PRO-INFLAMMATORY CYTOKINES, CHEMOKINES AND MATRIX METALLOPROTEINASES, WHEREAS ANTI-VIRAL GENES WERE TOLERIZABLE. IN MACROPHAGES, ALL MEASURED GENES WERE TOLERIZABLE, WHEREAS IN GINGIVAL AND FORESKIN FIBROBLASTS THESE GENES WERE NON-TOLERIZABLE. REPEATED STIMULATION OF SF WITH LPS RESULTED IN LOSS OF ACTIVATING HISTONE MARKS ONLY IN PROMOTERS OF TOLERIZABLE GENES. THE EPIGENETIC LANDSCAPE AT PROMOTERS OF TOLERIZABLE GENES WAS SIMILAR IN UNSTIMULATED SF AND MONOCYTES, WHEREAS THE BASAL CONFIGURATION OF HISTONE MARKS PROFOUNDLY DIFFERED IN GENES THAT WERE NON-TOLERIZABLE IN SF ONLY. OUR DATA SUGGEST THAT THE EPIGENETIC CONFIGURATION AT GENE PROMOTERS REGULATES CELL-SPECIFIC LPS-INDUCED RESPONSES AND PRIMES SF TO SUSTAIN THEIR INFLAMMATORY RESPONSE IN CHRONIC ARTHRITIS. 2017